Media Summary: Andrés Ferreri, MD, of the IRCCS San Raffaele Hospital, Milan, Italy, discusses current treatment Lymphoma Australia invites you to watch this recording of our educational webinar tailored to patients, families, and carers of ... Andrés Ferreri, MD, of the IRCCS San Raffaele Hospital, Milan, Italy, discusses new treatment

Pcnsl What Options Are Available - Detailed Analysis & Overview

Andrés Ferreri, MD, of the IRCCS San Raffaele Hospital, Milan, Italy, discusses current treatment Lymphoma Australia invites you to watch this recording of our educational webinar tailored to patients, families, and carers of ... Andrés Ferreri, MD, of the IRCCS San Raffaele Hospital, Milan, Italy, discusses new treatment Leading cancer specialist Dr. Christian Grommes reveals key facts, symptoms, and treatment breakthroughs for primary central ... MATRix immunochemotherapy induction therapy has produced promising results in the recent IELSG 32 trial (NCT01011920) for ... Expert Dr. Christian Grommes explains primary central nervous system lymphoma (

Real World Outcomes and Prognostication of Older In this video, Kathryn Tringale, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses a study which ... Trent Wang, DO, MPH, Sylvester Comprehensive Cancer Center, Miami Springs, FL, discusses the role of thiotepa-containing ... Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management Lakshmi Nayak, MD, Dana-Farber Cancer Institute, Boston, MA, shares insights into the neurological symptoms associated with ... Have you or a loved one been diagnosed with CNS lymphoma? Join this webinar to learn more the diagnosis, symptoms and side ...

Photo Gallery

PCNSL: what options are available?
Updates in Primary Central Nervous System Lymphoma (PCNSL)
Novel therapies for PCNSL
What is PCNSL?
Primary CNS lymphoma: can we use MATRix immunochemo in the real world?
PCNSL Treatment Options
Primary CNS lymphoma
Real World Outcomes and Prognostication of Older PCNSL in the Contemporary Era
Evaluating longitudinal consolidation patterns in patients with primary CNS lymphoma
Thiotepa-containing regimens for PCNSL patients undergoing autoHCT
Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
Neurological symptoms indicative of primary CNS lymphoma: advice for community physicians
Sponsored
View Detailed Profile
PCNSL: what options are available?

PCNSL: what options are available?

Andrés Ferreri, MD, of the IRCCS San Raffaele Hospital, Milan, Italy, discusses current treatment

Updates in Primary Central Nervous System Lymphoma (PCNSL)

Updates in Primary Central Nervous System Lymphoma (PCNSL)

Lymphoma Australia invites you to watch this recording of our educational webinar tailored to patients, families, and carers of ...

Novel therapies for PCNSL

Novel therapies for PCNSL

Andrés Ferreri, MD, of the IRCCS San Raffaele Hospital, Milan, Italy, discusses new treatment

What is PCNSL?

What is PCNSL?

Leading cancer specialist Dr. Christian Grommes reveals key facts, symptoms, and treatment breakthroughs for primary central ...

Primary CNS lymphoma: can we use MATRix immunochemo in the real world?

Primary CNS lymphoma: can we use MATRix immunochemo in the real world?

MATRix immunochemotherapy induction therapy has produced promising results in the recent IELSG 32 trial (NCT01011920) for ...

Sponsored
PCNSL Treatment Options

PCNSL Treatment Options

Expert Dr. Christian Grommes explains primary central nervous system lymphoma (

Primary CNS lymphoma

Primary CNS lymphoma

... know about

Real World Outcomes and Prognostication of Older PCNSL in the Contemporary Era

Real World Outcomes and Prognostication of Older PCNSL in the Contemporary Era

Real World Outcomes and Prognostication of Older

Evaluating longitudinal consolidation patterns in patients with primary CNS lymphoma

Evaluating longitudinal consolidation patterns in patients with primary CNS lymphoma

In this video, Kathryn Tringale, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses a study which ...

Thiotepa-containing regimens for PCNSL patients undergoing autoHCT

Thiotepa-containing regimens for PCNSL patients undergoing autoHCT

Trent Wang, DO, MPH, Sylvester Comprehensive Cancer Center, Miami Springs, FL, discusses the role of thiotepa-containing ...

Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management

Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management

Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management

Neurological symptoms indicative of primary CNS lymphoma: advice for community physicians

Neurological symptoms indicative of primary CNS lymphoma: advice for community physicians

Lakshmi Nayak, MD, Dana-Farber Cancer Institute, Boston, MA, shares insights into the neurological symptoms associated with ...

What to Know When Newly Diagnosed with Primary CNS Lymphoma

What to Know When Newly Diagnosed with Primary CNS Lymphoma

Have you or a loved one been diagnosed with CNS lymphoma? Join this webinar to learn more the diagnosis, symptoms and side ...